Showing 1 - 20 results of 23 for search 'Mats Jerkeman', query time: 4.81s
Refine Results
-
1
-
2
-
3
S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R-POLA-MINI-CHP AND R-MINI-CHOP by Mats Jerkeman, Sirpa Leppä, Julian Hamfjord, Peter Brown, Sara Ekberg, Andrés José María Ferreri
Published 2023-08-01
Article -
4
HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis by Selamawit F. Mekuria, Sydney Timmermans, Christer Borgfeldt, Mats Jerkeman, Pia Johansson, Ditte Søndergaard Linde
Published 2023-06-01
Article -
5
-
6
Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer. by Sven-Erik Olofsson, Björn Nodin, Alexander Gaber, Jakob Eberhard, Mathias Uhlén, Karin Jirström, Mats Jerkeman
Published 2015-01-01
Article -
7
-
8
Clinical Characteristics and Histopathological Patterns of Hodgkin Lymphoma and Treatment Outcomes at a Tertiary Cancer Center in Ethiopia by Makka Adam, Yonas Bekueretsion, Abdulaziz Abubeker, Fisihatsion Tadesse, Anna Kwiecinska, Rawleigh Howe, Beyene Petros, Mats Jerkeman, Amha Gebremedhin
Published 2021-12-01
Article -
9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden by Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Bjorn E. Wahlin, Per-Ola Andersson, Karin E. Smedby
Published 2021-01-01
Article -
10
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic by Martin Dreyling, Igor Aurer, Massimo Federico, Mats Jerkeman, Marie Jose Kersten, Kim Linton, Ulrich Mey, Herve Tilly, Christian Buske
Published 2021-02-01
Article -
11
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity by Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman, Sara Ek
Published 2018-04-01
Article -
12
Tackling Mantle Cell Lymphoma in Europe by Denis Horgan, Jan Walewski, Igor Aurer, Carlo Visco, Eva Giné, Bogdan Fetica, Mats Jerkeman, Marta Kozaric, Maria Gomes da Silva, Martin Dreyling
Published 2022-09-01
Article -
13
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project by Mats Jerkeman, Sara Ekberg, Ingrid Glimelius, Alexandra Albertsson-Lindblad, Joshua P. Entrop, Fredrik Ellin, Kristina Sonnevi, Catharina Lewerin, Lena Brandefors, Karin E. Smedby
Published 2023-08-01
Article -
14
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma by Lavanya Lokhande, Venera Kuci Emruli, Christian Winther Eskelund, Arne Kolstad, Martin Hutchings, Riikka Räty, Carsten Utoft Niemann, Kirsten Grønbæk, Mats Jerkeman, Sara Ek
Published 2022-07-01
Article -
15
The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma... by Kathrine T. Isaksen, Klaus Beiske, Erlend B. Smeland, Judit Jørgensen, Marianne Brodtkorb, June Helen Myklebust, Mats Jerkeman, Leo Meriranta, Marja‐Liisa Karjalainen‐Lindsberg, Sirpa Leppä, David W. Scott, Harald Holte, Yngvild Nuvin Blaker
Published 2021-02-01
Article -
16
Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma. by Minna Taskinen, Riku Louhimo, Satu Koivula, Ping Chen, Ville Rantanen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Björkholm, Øystein Fluge, Lars Møller Pedersen, Karin Fjordén, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppä
Published 2014-01-01
Article -
17
An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement by Andrew J. Sunderland, Raphael E. Steiner, Musa Al Zahrani, Chelsea C. Pinnix, Bouthaina Shbib Dabaja, Jillian R. Gunther, Loretta J. Nastoupil, Mats Jerkeman, David Joske, Gavin Cull, Tarec El‐Galaly, Diego Villa, Chan Yoon Cheah
Published 2020-01-01
Article -
18
Is Good Clinical Practice Becoming Poor Clinical Care? by Steven Le Gouill, Martin Dreyling, Maria Dolores Caballero, Marc Andre, Jeannette Doorduijn, Wojciech Jurczak, Mats Jerkeman, Paolo Ghia, Pier-Luigi Zinzani, Maria Gomez Da Silva, Meletios Dimopoulos, Marek Trneny, Richard Delarue, Jan Walewski, Christian Gisselbrecht, Armando López-Guillermo, Simon Rule
Published 2017-12-01
Article -
19
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study by Lucia Morello, Sara Rattotti, Laura Giordano, Mats Jerkeman, Tom van Meerten, Katarzyna Krawczyk, Filipa Moita, Dario Marino, Simone Ferrero, Michał Szymczyk, Igor Aurer, Tarec Christoffer El-Galaly, Alice Di Rocco, Carlo Visco, Giuseppe Carli, Irene Defrancesco, Carmelo Carlo-Stella, Martin Dreyling, Armando Santoro, Luca Arcaini
Published 2020-02-01
Article -
20
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3 by Christian Winther Eskelund, Kostas Dimopoulos, Arne Kolstad, Ingrid Glimelius, Riikka Räty, Lise Mette Rahbek Gjerdrum, Kristina Sonnevi, Pär Josefsson, Herman Nilsson-Ehle, Hans H. N. Bentzen, Unn Merete Fagerli, Outi Kuittinen, Jacob Haaber, Carsten Utoft Niemann, Lone Bredo Pedersen, Maria Torp Larsen, Christian Hartmann Geisler, Martin Hutchings, Mats Jerkeman, Kirsten Grønbæk
Published 2021-01-01
Article